| Turkish Journal of Cancer |
| 2009, Volume 39, Number 1 |
| 7 article(s) found. |
Single-agent and combination chemotherapy in small cell lung cancer
ÖZGÜR ÖZYILKAN1, GÜLTEN TEKUZMAN1, AYŞE KARS1, İBRAHİM BARIŞTA1, EŞMEN BALTALI1, ŞEVKET RUACAN2, YAVUZ ÖZIŞIK1, EMİN KANSU1, DİNÇER FIRAT1 |
Cyclophosphamide, epirubicin, and etoposide alternating with cisplatin and etoposide in small cell lung cancer
ÖZGÜR ÖZYILKAN, AYŞE KARS, GÜLTEN TEKUZMAN, EŞMEN BALTALI, DİNÇER FIRAT |
High dose epirubicin and ifosfamide alternating with etoposide and cisplatin therapy with granulocyte macrophage colony stimulating factor in small cell lung cancer
ÖNDER BERK1, HALUK ONAT2, AYŞE KARS3, SÜHEYLA SERDENGEÇTİ4, NAZAN GÜNEL5, FARUK AYKAN2, SAİT OKKAN4, MÜNİR KINAY6, NECDET ÜSKENT7, GÜRSEL AKTAN8, DİNÇER FIRAT3 |
Is the third-line chemotherapy feasible for non-small cell lung cancer? A retrospective study
MUSTAFA ÖZDOĞAN, MUSTAFA SAMUR, HAKAN BOZCUK, ERKAN ÇOBAN, MEHMET ARTAÇ, BURHAN SAVAŞ |
Serum tumor markers in small cell lung carcinoma patients treated with cyclophosphamide, epirubicin and vincristine combination
HASAN ŞENOL COŞKUN1, ÖZLEM ER2, MUSTAFA ALTINBAŞ2, METİN ÖZKAN2, SERDAR SOYUER2 |
CYP1A1, GSTM1 and NQO1 gene polymorphisms: Genetic risk factors for small cell lung cancer
AYŞE DEMİRKAN1, BURÇAK VURAL1, ZEKİ ÜSTÜNER2, KAZIM UYGUN3, BETÜL ÖZTÜRK AÇIKALIN4, DUYGU DERİN4, PINAR SAİP4, UĞUR ÖZBEK1 |
Single-agent vinorelbine as third-line chemotherapy for refractory non-small cell lung cancer
ÖZKAN KANAT1, FATİH ÖLMEZ2, ENDER KURT1, ABDÜLMECİT YILDIZ2, TÜRKKAN EVRENSEL1, ELVAN KANAT3, OSMAN MANAVOĞLU1 |
|
Turkish Journal of Cancer web sitesi Novartis Onkoloji'nin karşılıksız eğitim katkılarıyla hazırlanmıştır.
|
